Itron, Inc. (NASDAQ:ITRI) Shares Bought by Cerity Partners LLC

Cerity Partners LLC raised its holdings in Itron, Inc. (NASDAQ:ITRI) by 52.7% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 4,928 shares of the scientific and technical instruments company’s stock after purchasing an additional 1,701 shares during the period. Cerity Partners LLC’s holdings in Itron were worth $516,000 as of its most recent SEC filing.

A number of other institutional investors also recently made changes to their positions in ITRI. Janney Montgomery Scott LLC increased its holdings in shares of Itron by 0.7% in the 1st quarter. Janney Montgomery Scott LLC now owns 16,795 shares of the scientific and technical instruments company’s stock valued at $1,759,000 after acquiring an additional 121 shares during the last quarter. CoreCap Advisors LLC increased its holdings in shares of Itron by 25.5% in the 4th quarter. CoreCap Advisors LLC now owns 616 shares of the scientific and technical instruments company’s stock valued at $67,000 after acquiring an additional 125 shares during the last quarter. Captrust Financial Advisors increased its holdings in shares of Itron by 6.3% in the 4th quarter. Captrust Financial Advisors now owns 2,144 shares of the scientific and technical instruments company’s stock valued at $233,000 after acquiring an additional 128 shares during the last quarter. Summit Investment Advisors Inc. increased its holdings in shares of Itron by 3.1% in the 4th quarter. Summit Investment Advisors Inc. now owns 4,726 shares of the scientific and technical instruments company’s stock valued at $513,000 after acquiring an additional 140 shares during the last quarter. Finally, Merit Financial Group LLC increased its holdings in shares of Itron by 6.7% in the 1st quarter. Merit Financial Group LLC now owns 2,962 shares of the scientific and technical instruments company’s stock valued at $310,000 after acquiring an additional 187 shares during the last quarter. 96.19% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, SVP Christopher E. Ware sold 339 shares of the company’s stock in a transaction on Tuesday, May 27th. The stock was sold at an average price of $114.95, for a total value of $38,968.05. Following the completion of the sale, the senior vice president owned 19,468 shares in the company, valued at $2,237,846.60. This represents a 1.71% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, SVP John F. Marcolini sold 3,783 shares of the company’s stock in a transaction on Tuesday, June 3rd. The shares were sold at an average price of $116.73, for a total value of $441,589.59. Following the completion of the sale, the senior vice president owned 21,865 shares of the company’s stock, valued at approximately $2,552,301.45. This trade represents a 14.75% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 20,905 shares of company stock valued at $2,439,202. 1.45% of the stock is currently owned by insiders.

Analysts Set New Price Targets

A number of research analysts recently commented on ITRI shares. Wall Street Zen downgraded Itron from a “buy” rating to a “hold” rating in a research note on Sunday, June 1st. Guggenheim restated a “buy” rating and set a $155.00 price objective (up from $133.00) on shares of Itron in a research note on Monday, July 14th. Piper Sandler lowered their price objective on Itron from $124.00 to $121.00 and set a “neutral” rating for the company in a research note on Monday, May 5th. JPMorgan Chase & Co. upped their price objective on Itron from $118.00 to $128.00 and gave the stock a “neutral” rating in a research note on Tuesday. Finally, Roth Capital upped their price objective on Itron from $130.00 to $150.00 and gave the stock a “buy” rating in a research note on Tuesday. Four investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $133.17.

Itron Trading Up 1.5%

NASDAQ:ITRI opened at $135.97 on Friday. The company has a debt-to-equity ratio of 0.52, a quick ratio of 1.65 and a current ratio of 1.93. The stock has a market cap of $6.20 billion, a price-to-earnings ratio of 24.81, a PEG ratio of 0.85 and a beta of 1.35. The business has a fifty day moving average of $126.68 and a 200-day moving average of $112.21. Itron, Inc. has a 1 year low of $90.11 and a 1 year high of $137.99.

Itron (NASDAQ:ITRI) last announced its quarterly earnings data on Thursday, May 1st. The scientific and technical instruments company reported $1.52 earnings per share for the quarter, beating the consensus estimate of $1.30 by $0.22. The business had revenue of $607.15 million during the quarter, compared to analyst estimates of $608.86 million. Itron had a return on equity of 19.65% and a net margin of 10.34%. The company’s revenue was up .6% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.24 earnings per share. Equities analysts predict that Itron, Inc. will post 5.33 earnings per share for the current year.

Itron Profile

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.